Patent details

Basic Information

Publication number:

EP3527574

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191670512

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY

French Title of Invention:

PROMÉDICAMENTS DE L'ALVOCIDIB À BIODISPONIBILITÉ AUGMENTÉE

German Title of Invention:

ALVOCIDIB-PRODRUGS MIT ERHÖHTER BIOVERFÜGBARKEIT

SPC Number:

Dates

Filing date:

18/05/2016

Grant date:

06/04/2022

EP Publication Date:

21/08/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/04/2022

EP B1 Publication Date:

06/04/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/05/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/07/2023

 

 

Name:

SUMITOMO PHARMA ONCOLOGY, INC.

Address:

84 Waterford Drive, MA 01752, Marlborough, , United States (US)

History of Owners

From:

27/05/2022

To:

12/07/2023

Name:

Sumitomo Pharma Oncology, Inc.

Address:

640 Memorial Drive, Cambridge, MA 02139, United States (US)

From:

30/03/2022

To:

27/05/2022

Name:

Sumitomo Dainippon Pharma Oncology, Inc.

Address:

640 Memorial Drive, Cambridge, MA 02139, United States (US)

Agent

Name:

VALIPAT

From:

07/06/2022

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

1

Name:

BEARSS, David J.

Address:

United States (US)

2

Name:

SIDDIQUI-JAIN, Adam

Address:

United States (US)

Priority

Priority Number:

201562163188 P

Priority Date:

18/05/2015

Priority Country:

United States (US)

Classification

IPC classification:

C07F 9/12; A61K 31/661; A61P 35/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/09

Publication date:

01/08/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202214

Publication date:

06/04/2022

Description:

Grant (B1)

2

Issue number:

202219

Publication date:

11/05/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202226

Publication date:

29/06/2022

Description:

Change of owner's name or address

Deed

Power of attorney

Change Kind/ Decision Type:

Assignment

Deed Number:

RC20220000213A

Date Registered:

07/06/2022

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

VALIPAT

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20230000311A

Date Registered:

12/07/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Dennemeyer & Associates S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

SUMITOMO PHARMA ONCOLOGY, INC.

Address:

84 Waterford Drive, MA 01752, Marlborough, , United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

02/06/2025

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/05/2024

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
12/07/2023	Request For Change	5
14/07/2023	Outgoing Correspondence	1
07/06/2022	Request For Change	2
07/06/2022	Outgoing Correspondence	2